# generate_tests\Test mAB\IgG1-K-002.txt
# Generated sample - 9953H|adalimumab beta|Homo sapiens||H-GAMMA-1 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (235-344) [D3] + CH3 (345-449) [D4])|||||||451|451|||MW undefined|MW undefined| - Trypsin - 50%
LSCAASGFTFDDYAMHWVR
GLEWVSAITWNSGHIDYADSVEGR
AEDTAVYYCAK
THTCPPCPAPELLGGPSVFLFPPKPK
FNWYVDGVEVHNAK
ALPAPIEK
GFYPSDIAVEWESNGQPENNYK
TTPPVLDSDGSFFLYSK
WQQGNVFSCSVMHEALHNHYTQK
SLSLSPGK
# Generated sample - 9953H|adalimumab beta|Homo sapiens||H-GAMMA-1 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (235-344) [D3] + CH3 (345-449) [D4])|||||||451|451|||MW undefined|MW undefined| - Chymotrypsin - 50%
VESGGGL
VQPGRSL
VSAITW
TISRDNAKNSL
RAEDTAVY
CAKVSY
STASSL
APSSKSTSGGTAAL
PEPVTVSW
ICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPEL
GGPSVF
PPKPKDTL
ISRTPEVTCVVVDVSHEDPEVKF
RVVSVL
PAPIEKTISKAKGQPREPQVY
ESNGQPENNY
QQGNVF
# Generated sample - 9953H|adalimumab beta|Homo sapiens||H-GAMMA-1 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (235-344) [D3] + CH3 (345-449) [D4])|||||||451|451|||MW undefined|MW undefined| - Aspecific - 50%
QLVESGGGLVQPGRSLRLSCAASGFTF
SGGGLVQPGRSLRLSCAASGFTFDDYAMHWVR
GRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSAITWN
RSLRLSCAASGFTFDDYAMHWVRQAPGKGLE
RLSCAASGFTFDDYAMHWVRQAPGKGLEWVSAITWNSGHI
LSCAASGFTFDDYAMHWVRQAPGK
DYAMHWVRQAPGKGLEWVSAITWNSGHIDY
HWVRQAPGKG
QAPGKGLEWVSAITWNSGHIDYADSVEGRFT
AITWNSGHIDYADSVEGRFTIS
SVEGRFTISRDN
VEGRFTISRDNAKNSLYLQMNSLRAEDT
EGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAKVSYLST
GRFTISRDNAKNSLYLQMNSLRAEDTAVY
MNSLRAEDTAVYYCAKVSY
SLRAEDTAVYYCAKVSYLSTASSLDYWGQGTLVTVSS
AEDTAVYYCAK
AEDTAVYYCAKVSYLSTASSLDYWGQG
SYLSTASSLDYWGQGTLVTVSSASTKGPSVFPLA
ASSLDYWGQGTLVTV
GQGTLVTVSSASTKGPSVFPLAPSSKSTSG
TAALGCLVKDYFPEPVTV
YFPEPVTV
VHTFPAV
SGLYSLSSVVTVPSSSL
YSLSSVVTVP
NHKPSNTKVDK
VEPKSCDKTHTCPPC
SCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPE
APELLGGPSVFLFPPKP
LLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHE
LGGPSVFLFP
GGPSVFLFPPKPKDT
PKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVE
VTCVVVDVSHED
VTCVVVDVSHEDPE
CVVVDVSHEDPEVKFNWYVDGVEV
NWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTV
GVEVHNAKTKPREEQYNSTYRVV
VHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYK
PREEQYNSTYRVVSV
REEQYNSTYRVVSVLTVLHQD
QDWLNGKEYKCKVSNK
LNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVY
KALPAPIEKTISK
EKTISKAKGQPRE
QPREPQVYTLPPSRDELTKNQVSLTC
QPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEW
TLPPSRDELTKNQVSLTCLVKGFY
PSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPE
RDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENN
KNQVSLTCLVKGFYPSDIAVEWE
SLTCLVKGFYPSDIAVEWESNGQPENNY
SDIAVEWESNGQPENNYKTTPPVLDS
AVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSR
VEWESNGQPEN
SNGQPENNYKTTPPV
KTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFS
SDGSFFLYSKLTVDKSRWQ
VDKSRWQQ
SCSVMHEALHN
# Generated sample - 9953L|adalimumab beta|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Trypsin - 50%
DIQMTQSPSSLSASVGDR
VTITCR
NYLAWYQQKPGK
LLIYAASTLQSGVPSR
TVAAPSVFIFPPSDEQLK
VDNALQSGNSQESVTEQDSK
VYACEVTHQGLSSPVTK
# Generated sample - 9953L|adalimumab beta|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Chymotrypsin - 50%
TQSPSSL
QSGVPSRF
KSGTASVVCL
PREAKVQW
EKHKVY
ACEVTHQGL
# Generated sample - 9953L|adalimumab beta|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Aspecific - 50%
CRASQGIRNYLAWYQQKPGKAPKLLIYAASTL
QSGVPSRFSGSGSGTDFTLTI
ATYYCQRYNRA
QRYNRAPYTFGQGTKVEIKRTVA
EQLKSGTASVVCLLNNFYPREAK
AKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSS
WKVDNALQSGNSQESVTEQDSK
GNSQESVTEQDSKDSTYSLSSTLTLSKADYEKH
